Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 233.36
+11.11 (5.00%)
Sep 8, 2025, 3:29 PM IST
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 53.21 billion as of September 8, 2025. Its market cap has increased by 68.26% in one year.
Market Cap
53.21B
Enterprise Value
52.61B
Revenue
75.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
233.36
Market Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 53.21B, an increase of 3,201.66%. That is a compound annual growth rate of 16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 50.68B | 81.57% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | 11.53B | -70.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.58B |
| Divi's Laboratories | 1,595.20B |
| Cipla | 1,254.77B |
| Apollo Hospitals Enterprise | 1,122.17B |
| Mankind Pharma | 1,052.78B |
| Zydus Lifesciences | 1,020.17B |
| Fortis Healthcare | 715.59B |
| Alkem Laboratories | 637.70B |